Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Share-based Compensation: 2010-2012

Historic Share-based Compensation for Lexicon Pharmaceuticals (LXRX) over the last 2 years, with Dec 2012 value amounting to $1.6 million.

  • Lexicon Pharmaceuticals' Share-based Compensation rose 17.52% to $1.6 million in Q4 2012 from the same period last year, while for Dec 2012 it was $6.5 million, marking a year-over-year increase of 13.81%. This contributed to the annual value of $13.5 million for FY2024, which is 5.86% down from last year.
  • Lexicon Pharmaceuticals' Share-based Compensation amounted to $1.6 million in Q4 2012, which was down 0.13% from $1.6 million recorded in Q3 2012.
  • Lexicon Pharmaceuticals' Share-based Compensation's 5-year high stood at $1.7 million during Q1 2012, with a 5-year trough of $1.3 million in Q3 2010.
  • For the 3-year period, Lexicon Pharmaceuticals' Share-based Compensation averaged around $1.5 million, with its median value being $1.5 million (2010).
  • In the last 5 years, Lexicon Pharmaceuticals' Share-based Compensation fell by 10.99% in 2011 and then increased by 17.52% in 2012.
  • Quarterly analysis of 3 years shows Lexicon Pharmaceuticals' Share-based Compensation stood at $1.5 million in 2010, then declined by 10.99% to $1.4 million in 2011, then increased by 17.52% to $1.6 million in 2012.
  • Its last three reported values are $1.6 million in Q4 2012, $1.6 million for Q3 2012, and $1.6 million during Q2 2012.